Methylation of the human pendrin promoter

Cellular Physiology and Biochemistry

Volumn 28, Issue 3, 2011, Pages 397-406

  Lee, Adam ^a   Nofziger, Charity ^b   Dossena, Silvia ^b   Vanoni, Simone ^b   Diasio, Robert ^a   Paulmichl, Markus ^b  

^a MAYO GRADUATE SCHOOL   (United States)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

Bisulfite modification; CpG; Epigenetics; HEK Blue; NCI H292; SLC26A4

Indexed keywords

INTERLEUKIN 4; MESSENGER RNA; PENDRIN;

ARTICLE; CELL SPECIFICITY; CPG ISLAND; DNA METHYLATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

EID: 82255167155     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000335102     Document Type: Article

References (50)

1. Wu C, Morris JR: Genes, genetics, and epigenetics: A correspondence. Science 2001;293:1103-1105. (Pubitemid 32758084)
2. Bonasio R, Tu S, Reinberg D: Molecular signals of epigenetic states. Science 2010;330:612-616.
3. Ang YS, Gaspar-Maia A, Lemischka IR, Bernstein E: Stem cells and reprogramming: Breaking the epigenetic barrier? Trends Pharmacol Sci 2011;32:394-401.
4. Hoelzinger DB, Mariani L, Weis J, Woyke T, Berens TJ, McDonough WS, Sloan A, Coons SW, Berens ME: Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia 2005;7:7-16. (Pubitemid 40209466)
5. Freije WA, Castro-Vargas FE, Fang Z, Horvath S, Cloughesy T, Liau LM, Mischel PS, Nelson SF: Gene expression profiling of gliomas strongly predicts survival. Cancer Res 2004;64:6503-6510. (Pubitemid 39297907)
6. Cadieux B, Ching TT, VandenBerg SR, Costello JF: Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation. Cancer Res 2006;66:8469-8476. (Pubitemid 44449159)
7. Issa JP: CpG island methylator phenotype in cancer. Nat Rev Cancer 2004;4:988-993.
8. Ezzeldin HH, Lee AM, Mattison LK, Diasio RB: Methylation of the DPYD promoter: An alternative mechanism for dihydropyrimidine dehydrogenase deficiency in cancer patients. Clin Cancer Res 2005;11:8699-8705. (Pubitemid 43005919)
9. Everett LA, Glaser B, Beck JC, Idol JR, Buchs A, Heyman M, Adawi F, Hazani E, Nassir E, Baxevanis AD, Sheffield VC, Green ED: Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet 1997;17:411-422. (Pubitemid 27518389)
10. Alesutan I, Pelzl L, C L, Voelkl J, Nofziger C, Dossena S, Paulmichl M, Lang F: Impact of bicarbonate, ammonium chloride, and acetazolamide on hepatic and renal Slc26a4 transcription. Cell Physiol Biochem 2011;28:553-558.
11. Bidart JM, Lacroix L, Evain-Brion D, Caillou B, Lazar V, Frydman R, Bellet D, Filetti S, Schlumberger M: Expression of Na+/I-symporter and Pendred syndrome genes in trophoblast cells. J Clin Endocrinol Metab 2000;85:4367-4372. (Pubitemid 32055400)
12. Lacroix L, Mian C, Caillou B, Talbot M, Filetti S, Schlumberger M, Bidart JM: Na+/I-symporter and Pendred syndrome gene and protein expressions in human extrathyroidal tissues. Eur J Endocrinol 2001;144:297-302. (Pubitemid 32266301)
13. Rillema JA, Hill MA: Pendrin transporter carries out iodide uptake into MCF-7 human mammary cancer cells. Exp Biol Med (Maywood) 2003;228:1078-1082. (Pubitemid 37222179)
14. Suzuki K, Royaux IE, Everett LA, Mori-Aoki A, Suzuki S, Nakamura K, Sakai T, Katoh R, Toda S, Green ED, Kohn LD: Expression of PDS/pds, the Pendred syndrome gene, in endometrium. J Clin Endocrinol Metab 2002;87:938-941. (Pubitemid 34158274)
15. Di Valentin E, Crahay C, Garbacki N, Hennuy B, Gueders M, Noel A, Foidart JM, Grooten J, Colige A, Piette J, Cataldo D: New asthma biomarkers: Lessons from murine models of acute and chronic asthma. Am J Physiol Lung Cell Mol Physiol 2009;296:L185-197.
16. Kuperman DA, Lewis CC, Woodruff PG, Rodriguez MW, Yang YH, Dolganov GM, Fahy JV, Erle DJ: Dissecting asthma using focused transgenic modeling and functional genomics. J Allergy Clin Immunol 2005;116:305-311. (Pubitemid 41096536)
17. Nakagami Y, Favoreto S Jr, Zhen G, Park SW, Nguyenvu LT, Kuperman DA, Dolganov GM, Huang X, Boushey HA, Avila PC, Erle DJ: The epithelial anion transporter pendrin is induced by allergy and rhinovirus infection, regulates airway surface liquid, and increases airway reactivity and inflammation in an asthma model. J Immunol 2008;181:2203-2210.
18. Nakao I, Kanaji S, Ohta S, Matsushita H, Arima K, Yuyama N, Yamaya M, Nakayama K, Kubo H, Watanabe M, Sagara H, Sugiyama K, Tanaka H, Toda S, Hayashi H, Inoue H, Hoshino T, Shiraki A, Inoue M, Suzuki K, Aizawa H, Okinami S, Nagai H, Hasegawa M, Fukuda T, Green ED, Izuhara K: Identification of pendrin as a common mediator for mucus production in bronchial asthma and chronic obstructive pulmonary disease. J Immunol 2008;180:6262-6269.
19. Nofziger C, Vezzoli V, Dossena S, Schonherr T, Studnicka J, Nofziger J, Vanoni S, Stephan S, Silva ME, Meyer G, Paulmichl M: STAT6 links IL-4/IL-13 stimulation with pendrin expression in asthma and chronic obstructive pulmonary disease. Clin Pharmacol Ther 2011;90:399-405.
20. Pedemonte N, Caci E, Sondo E, Caputo A, Rhoden K, Pfeffer U, Di Candia M, Bandettini R, Ravazzolo R, Zegarra-Moran O, Galietta LJ: Thiocyanate transport in resting and IL-4-stimulated human bronchial epithelial cells: Role of pendrin and anion channels. J Immunol 2007;178:5144-5153. (Pubitemid 46595298)
21. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402-408. (Pubitemid 34164012)
22. Xing M, Tokumaru Y, Wu G, Westra WB, Ladenson PW, Sidransky D: Hypermethylation of the Pendred syndrome gene SLC26A4 is an early event in thyroid tumorigenesis. Cancer Res 2003;63:2312-2315. (Pubitemid 36538642)
23. Christman JK: Separation of major and minor deoxyribonucleoside monophosphates by reverse-phase high-performance liquid chromatography: A simple method applicable to quantitation of methylated nucleotides in DNA. Anal Biochem 1982;119:38-48. (Pubitemid 12142838)
24. Gardiner-Garden M, Frommer M: CpG islands in vertebrate genomes. J Mol Biol 1987;196:261-282. (Pubitemid 17122132)
25. Larsen F, Gundersen G, Lopez R, Prydz H: CpG islands as gene markers in the human genome. Genomics 1992;13:1095-1107.
26. Jaenisch R, Bird A: Epigenetic regulation of gene expression: How the genome integrates intrinsic and environmental signals. Nat Genet 2003;33 S:245-254. (Pubitemid 36278835)
27. Egger G, Liang G, Aparicio A, Jones PA: Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004;429:457-463. (Pubitemid 38715140)
28. Adler L, Efrati E, Zelikovic I: Molecular mechanisms of epithelial cell-specific expression and regulation of the human anion exchanger (pendrin) gene. Am J Physiol Cell Physiol 2008;294:C1261-1276.
29. Blomqvist SR, Vidarsson H, Fitzgerald S, Johansson BR, Ollerstam A, Brown R, Persson AE, Bergstrom G, Enerback S: Distal renal tubular acidosis in mice that lack the forkhead transcription factor Foxi1. J Clin Invest 2004;113:1560-1570. (Pubitemid 39071679)
30. Blomqvist SR, Vidarsson H, Soder O, Enerback S: Epididymal expression of the forkhead transcription factor Foxi1 is required for male fertility. EMBO J 2006;25:4131-4141. (Pubitemid 44338753)
31. Dentice M, Luongo C, Elefante A, Ambrosio R, Salzano S, Zannini M, Nitsch R, Di Lauro R, Rossi G, Fenzi G, Salvatore D: Pendrin is a novel in vivo downstream target gene of the TTF-1/Nkx-2.1 homeodomain transcription factor in differentiated thyroid cells. Mol Cell Biol 2005;25:10171-10182. (Pubitemid 41572761)
32. Jonard L, Niasme-Grare M, Bonnet C, Feldmann D, Rouillon I, Loundon N, Calais C, Catros H, David A, Dollfus H, Drouin-Garraud V, Duriez F, Eliot MM, Fellmann F, Francannet C, Gilbert-Dussardier B, Gohler C, Goizet C, Journel H, Mom T, Thuillier-Obstoy MF, Couderc R, Garabedian EN, Denoyelle F, Marlin S: Screening of SLC26A4, FOXI1 and KCNJ10 genes in unilateral hearing impairment with ipsilateral enlarged vestibular aqueduct. Int J Pediatr Otorhinolaryngol 2010;74:1049-1053.
33. Yang T, Vidarsson H, Rodrigo-Blomqvist S, Rosengren SS, Enerback S, Smith RJ: Transcriptional control of SLC26A4 is involved in Pendred syndrome and nonsyndromic enlargement of vestibular aqueduct (DFNB4). Am J Hum Genet 2007;80:1055-1063. (Pubitemid 47579342)
34. Izuhara K, Ohta S, Shiraishi H, Suzuki S, Taniguchi K, Toda S, Tanabe T, Yasuo M, Kubo K, Hoshino T, Aizawa H: The mechanism of mucus production in bronchial asthma. Curr Med Chem 2009;16:2867-2875.
35. Doi A, Park IH, Wen B, Murakami P, Aryee MJ, Irizarry R, Herb B, Ladd-Acosta C, Rho J, Loewer S, Miller J, Schlaeger T, Daley GQ, Feinberg AP: Differential methylation of tissue-and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 2009;41:1350-1353.
36. Dudziec E, Miah S, Choudhry HM, Owen HC, Blizard S, Glover M, Hamdy FC, Catto JW: Hypermethylation of CpG islands and shores around specific micrornas and mirtrons is associated with the phenotype and presence of bladder cancer. Clin Cancer Res 2011;17:1287-1296.
37. Portela A, Esteller M: Epigenetic modifications and human disease. Nat Biotechnol 2010;28:1057-1068.
38. Pollard SM, Stricker SH, Beck S: Preview. A shore sign of reprogramming. Cell Stem Cell 2009;5:571-572.
39. Liu H, Zhang L, Niu Z, Zhou M, Peng C, Li X, Deng T, Shi L, Tan Y, Li G: Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells. BMC Cancer 2008;8:253.
40. Qiang M, Denny A, Chen J, Ticku MK, Yan B, Henderson G: The site specific demethylation in the 5'-regulatory area of NMDA receptor 2B subunit gene associated with CIE-induced up-regulation of transcription. PLoS One 2010;5:e8798.
41. Weih F, Nitsch D, Reik A, Schutz G, Becker PB: Analysis of CpG methylation and genomic footprinting at the tyrosine aminotransferase gene: DNA methylation alone is not sufficient to prevent protein binding in vivo. EMBO J 1991;10:2559-2567. (Pubitemid 21905730)
42. Aoki M, Terada T, Kajiwara M, Ogasawara K, Ikai I, Ogawa O, Katsura T, Inui K: Kidney-specific expression of human organic cation transporter 2 (OCT2/SLC22A2) is regulated by DNA methylation. Am J Physiol Renal Physiol 2008;295:F165-170.
43. Holgate ST: Pathophysiology of asthma: What has our current understanding taught us about new therapeutic approaches? J Allergy Clin Immunol 2011;122:495-505.
44. Barnes PJ: New therapies for chronic obstructive pulmonary disease. Med Princ Pract 2010;19:330-338.
45. Sakao S, Tatsumi K: The importance of epigenetics in the development of chronic obstructive pulmonary disease. Respirology 2011;16:1056-1063.
46. Koppelman GH, Nawijn MC: Recent advances in the epigenetics and genomics of asthma. Curr Opin Allergy Clin Immunol 2011;11:414-419.
47. Yang IV, Schwartz DA: Epigenetic control of gene expression in the lung. Am J Respir Crit Care Med 2011;183:1295-1301.
48. North ML, Ellis AK: The role of epigenetics in the developmental origins of allergic disease. Ann Allergy Asthma Immunol 2011;106:355-361; quiz 362.
49. Durham AL, Wiegman C, Adcock IM: Epigenetics of asthma. Biochim Biophys Acta 2011
50. Martino D, Prescott S: Epigenetics and prenatal influences on asthma and allergic airways disease. Chest 2011;139:640-647.